Frontiers Pharmacokinetics, distribution, metabolism, and excretion of body protective compound 157, a potential drug for treating various wounds, in rats and dogs Revolutionizing Recovery: How Dr. Lundquist is Using BPC 157, TB 500, and Regenerative Therapies to Accelerate Healing Active Life Pain Center BPC 157 Dosing (Common Protocols), Oral Subcutaneous, 500 mcg daily, Duration: 6 weeks, Intramuscular Peritendinous, 1 mg daily, Duration: 6 weeks, Note:, Not approved by FDA or Thinking about BPC 157? Read this first. 5 things to know before your first reconstitution what it actually does, the standard dose, the rest day mistake most people skip, and the legal status